RxDoctor Payments Data

Brian Rapp, MD

Vascular Surgery · Fort Smith, ARNPI 1407014657

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,493 of the $5,109 with a category attached, or 68.4%. It is spread thinly across 22 manufacturers, the largest accounting for just 20.6%. Reporting peaked in 2019 at $1,767 and has fallen 81.3% since, to $330 in 2025.

$5,109in general payments, 2019–2025

Across 65 payments — averaging $78.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$1K
  • Silk Road Medical, Inc.$1K
  • W. L. Gore & Associates, Inc.$754
  • Boston Scientific$608
  • Medtronic$390
  • Abbott$304
  • plus $957 from 16 others

What the payments were for

  • Travel & lodging$1,58831%
  • Food & beverage$3,49368%
  • Entertainment$281%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few vascular surgery providers in Arkansasto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$109,963
Medicare patients
498
Services billed
1,310

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$10,276
Cilostazol117$1,663
ClopidogrelClopidogrel Bisulfate116$817
Gabapentin27$434
Atorvastatin Calcium37$188
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$119
Pantoprazole Sodium12$81
Hydrochlorothiazide12$8

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →